| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |